Supplier Type
- Manufacturer
- Trader
- Reagent
- contract manufacturer
- custom synthesis
Supplier Region
- Telangana(1)
- Hyderabad(8)
- Vadodara(1)
- Mumbai(9)
- Maharashtra(7)
- Bangalore(2)
- New Delhi(5)
- Gujarat(7)
- Karnataka(2)
- Delhi(1)
- Tamil Nadu(1)
- Ahmedabad(2)
- Andhra Pradesh(2)
- Himachal Pradesh(1)
Purity
- NLT 95%
- Crude
- ABOVE 99%
- 99.99%
- 99.68%
- 99.40%
- 99.34%
- 99.23%
- 99%
- 98+
- 98.00%
- 98%
- 97-99%
- 97%
- >97%
- 95.00%
- 90 % Above
- 86.50%
- 82.70%
- 72.96%
- 25 MG 50 MG 100 MG 250 MG EXTRA
Package
- 1mg
- 1g
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1gm
- 5g
- 10g
- 25g
- 50g
- 100g
- 500g
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1MT
- 1and gm
- 95NLT %
- 250250 mg.
-
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
32384-65-9
-
Uridine
58-96-8
-
4-AMINO-5-CYANO-7-(BETA-D-RIBOFURANOSYL)PYRROLO[2,3-D]PYRIMIDINE
606-58-6
-
(3r,4r)-1-benzyl-4-hydroxy-3-pyrrolidinemethanol
253129-03-2
-
Rosuvastatin calcium
147098-20-2
-
DL-Tartaric acid
133-37-9
-
Tramadol Impurity 2
187219-95-0
-
(3R,4S)-3-Hydroxy-4-methyl-piperidine-1-carboxylic acid tert-butyl ester
1932302-38-9
-
(3R,3aR,6aS)-Hexahydrofuro[2,3-b]furan-3-yl 4-Nitrophenyl Ester Carbonic Acid
252873-51-1
-
1-(((2S,3R)-2-(2,4-difluorophenyl)-3-Methyloxiran-2-yl)Methyl)-1H-1,2,4-triazole
135270-07-4
(3R,4R)-1-Benzyl-4-hydroxy-3-pyrrolidinemethanol 253129-03-2
Rosuvastatin Calcium 147098-20-2
(2R,3R)-rel-2,3-dihydroxy-Butanedioic acid 133-37-9
(1R,3R,6R)-Axomadol; 187219-95-0
Efinaconazole (2S,3R) Epoxide 135270-07-4
Rosuvastatin impurity B [Ca salt]
(-)-2,3-O-Isopropylidene-L-tartaric Acid Dimethyl Ester; dimethyl (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate; Dimethyl (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate; (4R,5R)-Dimethyl 2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate; (?)-Dimethyl 2,3-O-isopropylidene-L-tartrate; Dimethyl (-)-2,3-O-Isopropylidene-L-tartrate; 37031-29-1
(3R,4S)-1-((benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid 1428243-24-6